Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness
Clinical trial NCT00203021 · COMPLETED
Trial details
- NCT number
- NCT00203021
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1994-03-26
- Primary completion
- 2018-02-28
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.